Categories
Skin Cancer

Former Yahoo CEO Marissa Mayer on the Future of AI and Pioneering Transformative Technology [Video]

Dean Lloyd Minor welcomes Marissa Mayer, former Yahoo CEO, early Google employee and co-founder of Sunshine, for a conversation about the past, present, and future of AI and lessons learned from the evolution of search engine technology. They explore her experience pioneering iconic Google applications, what to expect as AI technology matures, and what it will take for a company to distinguish itself in the competitive world of AI. They also discuss the importance of building AI systems around the human experience, how to best regulate emerging technologies, and how to earn the public’s trust when developing transformative innovations.Marissa Mayer is a prominent technology executive and businesswoman, best known for her significant contributions to Google and Yahoo. In 1999, Mayer joined Google as their 20th employee and played a pivotal role in shaping the company’s iconic user experience and search functionality. During her tenure, she held various leadership positions, including vice president of search products and user experience. In 2012, Mayer took on the role of CEO at Yahoo, aiming to revitalize the struggling internet giant. Mayer’s tenure at Yahoo ended in 2017, and since then, she co-founded the startup Lumi Labs — now Sunshine — which aims to improve users’ iPhone contacts and Google contacts using intelligent algorithms and other functionalities. She holds a bachelor’s degree in symbolic systems and a master’s degree in computer science from Stanford University.Subscribe: TheMinorConsult.comAbout The Minor Consult Podcast The Minor Consult explores what it means to be a great leader in times of great uncertainty. Hosted by Stanford School of Medicine Dean Lloyd Minor, MD, the podcast convenes top minds from across fields to share their perspectives, impart lessons from their careers, and discuss the complex challenges leaders face today. Through their conversations, Dr. Minor unearths the qualities and skills that leaders need to succeed in turbulent times. Dr. Minor has served as Dean since 2012 and is also a professor of Otolaryngology–Head and Neck Surgery at the Stanford School of Medicine. Under his leadership, Stanford Medicine has emerged as a leader in the Precision Health revolution, which emphasizes preventive, personalized health care and leverages advances in biomedicine to treat and cure complex diseases. With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. In 2012, he was elected to the National Academy of Medicine. Disclaimer: Lloyd Minor has no financial interests in or formal relationships with the organizations of his guests….Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children’s Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.

Categories
Skin Cancer

Khloé Kardashian Reveals Skin Cancer Removal Left Face Indentation | E! News [Video]

Khloé Kardashian is getting candid about her journey with skin cancer. “The Kardashians” star shares she underwent a procedure to fill a cheek indentation, which developed after she had a tumor removed from her face.Full Story: https://www.eonline.com/news/1385959/khloe-kardashian-details-cosmetic-procedure-that-helped-fill-her-cheek-indentation-after-health-scare?source=youtube&medium=enews#KhloéKardashian #ENewsSubscribe: http://bit.ly/enewssubAbout E! News:The E! News team brings you the latest breaking entertainment, fashion and Pop Culture news. Featuring exclusive segments, celebrity highlights, trend reports and more, the E! News channel is the only destination Pop Culture fans need to stay in the know.Download The E! News App For The Latest Celebrity News and Trending Videos: https://eonline.onelink.me/yMtl/4ead5017Your favorite shows, movies and more are here. Stream now on Peacock. https://bit.ly/PeacockEEntConnect with E! News:Visit the E! News WEBSITE: http://eonli.ne/enewsLike E! News on FACEBOOK: https://www.facebook.com/enews/Check out E! News on INSTAGRAM: https://www.instagram.com/enews/Follow E! News on TWITTER: https://twitter.com/enewsKhloé Kardashian Reveals Skin Cancer Removal Left Face Indentation | E! Newshttp://www.youtube.com/user/enews

Categories
Skin Cancer

Scancell CEO hails “exciting” high response rate to melanoma treatment [Video]

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage biopharmaceutical company’s Phase 2 SCOPE trial in advanced melanoma.Professor Durrant gives an overview of the findings so far, saying that in the initial 11 patients they have achieved an impressive 82% overall response rate, surpassing the anticipated 70%. This development could be crucial for metastatic melanoma patients, as previous studies reported only a 50% response rate. She adds that the potential to significantly improve outcomes is especially significant given the rising cases, particularly among young women. While further confirmation is needed in a larger cohort, the data’s strength suggests promising results in the broader study. Looking ahead, the trial aims to recruit 43 patients, expecting over 27 respondents, with potential adjustments based on the remarkable initial response rate. Professor Durrant also provides an update on Modi1 vaccine and Scancell’s antibody platform.#ScancellHoldings #LindyDurrant #PhaseTwoScopeTrial #CancerVaccine #CheckpointInhibitors #MelanomaTreatment #ClinicalTrialResults #BiopharmaCompany #MetastaticMelanoma #MedicalBreakthrough #Immunotherapy #CancerResearch #HealthcareInnovation #OncologyAdvancements #MedicalScience #ClinicalStageTrials #CancerTreatmentOptions #Biopharmaceuticals #InnovationsInMedicine #MedicalResearchInsights#ProactiveInvestors #Scancell #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Categories
Skin Cancer

Mole Mapping: Early Detection For Skin Cancer [Video]

The detection of melanoma can sometimes be challenging even for professionals. There are various methods for the early diagnosis of melanoma, including annual full body skin exams with a healthcare provider and monthly skin self-exams. One of the more advanced methods is mole mapping. Mole mapping is a painless and noninvasive approach to help detect melanoma that uses whole body photography to identify new moles and track changes in existing moles. A doctor or nurse uses a specialized device to take high-resolution digital photos of your entire body. The photos are combined into a complete image of your body.The information in this video is correct as of 07 September 2023.For more information about melanoma or to ask Melissa a question, visit: https://www.aimatmelanoma.org/Twitter: https://twitter.com/AIMatMelanomaFacebook: https://www.facebook.com/AIMatMelanomaInstagram: https://www.instagram.com/AIMatMelanoma